[PP.14.03] Plasma Markers of Endothelial Dysfunction in Patients With Hypertension and Atrial Fibrillation

Подзолков, В. И.; Тарзиманова, А. И.; Pisarev, M.; Gataulin, R.

doi:10.1097/01.hjh.0000491909.87663.77

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Power calculations based on data from a previous similar study 26 indicate that for an alpha of 0.05 and power of 0.8, 30 participants are sufficient to detect a significant difference in FMD between groups of 1.7 percentage points. Cardiovascular measures (e.g.…”

Section: Statisticsmentioning

confidence: 93%

Chronic E-Cigarette Use Impairs Endothelial Function on the Physiological and Cellular Levels

Mohammadi

Han

et al. 2022

ATVB

View full text Add to dashboard Cite

Background: The harmful vascular effects of smoking are well established, but the effects of chronic use of electronic cigarettes (e-cigarettes) on endothelial function are less understood. We hypothesized that e-cigarette use causes changes in blood milieu that impair endothelial function. Methods: Endothelial function was measured in chronic e-cigarette users, chronic cigarette smokers, and nonusers. We measured effects of participants’ sera, or e-cigarette aerosol condensate, on NO and H 2 O 2 release and cell permeability in cultured endothelial cells (ECs). Results: E-cigarette users and smokers had lower flow-mediated dilation (FMD) than nonusers. Sera from e-cigarette users and smokers reduced VEGF (vascular endothelial growth factor)-induced NO secretion by ECs relative to nonuser sera, without significant reduction in endothelial NO synthase mRNA or protein levels. E-cigarette user sera caused increased endothelial release of H 2 O 2 , and more permeability than nonuser sera. E-cigarette users and smokers exhibited changes in circulating biomarkers of inflammation, thrombosis, and cell adhesion relative to nonusers, but with distinct profiles. E-cigarette user sera had higher concentrations of the receptor for advanced glycation end products (RAGE) ligands S100A8 and HMGB1 (high mobility group box 1) than smoker and nonuser sera, and receptor for advanced glycation end product inhibition reduced permeability induced by e-cigarette user sera but did not affect NO production. Conclusions: Chronic vaping and smoking both impair FMD and cause changes in the blood that inhibit endothelial NO release. Vaping, but not smoking, causes changes in the blood that increase microvascular endothelial permeability and may have a vaping-specific effect on intracellular oxidative state. Our results suggest a role for RAGE in e-cigarette-induced changes in endothelial function.

show abstract

Section: Statisticsmentioning

confidence: 93%